SBIR/STTR Research Award
NanoVector Vaccine Potentiation
Award amount
$100,000Program and phase
SBIR · Phase IAward year
2015Award details
- Awarding agency
- Department of Defense
- Branch
- Army
- Recipient company
- OCEANIT LABORATORIES INC
- Proposal award date
- 2015-09-30
- Contract end date
- 2016-04-29
- UEI
- S6X8FST9JAM7
- Solicitation number
- 2015.1
- Topic code
- A15-053
Research abstract
Oceanit proposes to develop and test novel vectors for delivery of broadly neutralizing monoclonal antibodies (bmAbs), vaccines antigens, or antiretroviral (ARV) therapies to treat or prevent HIV infection at mucosal surfaces.
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Binary-Level Automated Vulnerability Detection and Patching without Source Code
- MOF MAP Controlled Ripening Technology for Extended Shelf Life
- Holistic Exploitation of Logistical Information for Operations Susceptibility (HELIOS) Phase 2
- RAPID - Root Analysis for Plant Improvement and Design
- Improved IC based Electricity to RF Conversion Efficiency Development
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Enhanced HIV Vaccine by CNT-enabled Mucosal Delivery
- Enhanced HIV Vaccine by CNT-enabled Mucosal Delivery
Research funding history
278 SBIR/STTR records share this UEI (1995–2026). Reported award amounts total $141,296,922. Reported amounts are not federal obligations.
Phases: Phase I, Phase II, Phase II – Direct to Phase II
Agencies: Department of Defense, Department of Energy, Department of Homeland Security, Department of Commerce, National Science Foundation, Department of Transportation